Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference

Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results

Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wed., November 24, 2021

Building Global Momentum for Interventions in Alzheimer's Disease - a Lausanne VIII Workshop Panel

Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference

Data Review by the Independent DSMB reported for Phase 2b/3 Trial of ANAVEX®2-73 for AD

Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market®

Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access

Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference

Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 in FragileX Syndrome